Pharma-Bio Serv, Inc.

OTC:PBSV

0.98 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 9.50916.97719.39920.11521.56419.50717.79715.57919.53723.38527.55533.06229.22719.93311.34611.47915.19616.20514.230.01
Cost of Revenue 6.99311.9114.51714.75514.89813.3312.11111.96813.75315.918.58221.22919.35513.0727.9547.649.4079.3818.1160
Gross Profit 2.5165.0664.8815.366.6676.1775.6873.6115.7837.4848.97311.8339.8726.8613.3933.8395.796.8246.1140.01
Gross Profit Ratio 0.2650.2980.2520.2660.3090.3170.320.2320.2960.320.3260.3580.3380.3440.2990.3340.3810.4210.431
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 0000004.5995.0365.8755.7036.1095.7624.1383.4092.7832.9233.1363.1762.0310.04
Selling & Marketing Expenses 00000000000000000000
SG&A 3.8043.9493.7079.2144.4414.484.5995.0365.8755.7036.1095.7624.1383.4092.7832.9233.1363.1762.0310.04
Other Expenses 000.0131.9780.0640.5270.436000000000000.1950
Operating Expenses 3.8043.9493.7079.2144.4414.484.5995.0365.8755.7036.1095.7624.1383.4092.7832.9233.1363.1762.2260.04
Operating Income -1.2881.1171.175-3.8542.2261.6971.088-1.425-0.0921.7812.8646.0725.7343.4520.610.9152.6543.6483.888-0.02
Operating Income Ratio -0.1350.0660.061-0.1920.1030.0870.061-0.091-0.0050.0760.1040.1840.1960.1730.0540.080.1750.2250.273-2
Total Other Income Expenses Net -754.160.570.0131.9780.0640.5270.4360.044-0.1120.0110.0140.0050.0220.0120.011-0.019-0.145-0.31-0.3930
Income Before Tax -755.4481.6871.188-1.8762.292.2231.524-1.411-0.2041.7932.8786.0765.7563.4640.6210.8962.5093.3373.495-0.02
Income Before Tax Ratio -79.4430.0990.061-0.0930.1060.1140.086-0.091-0.010.0770.1040.1840.1970.1740.0550.0780.1650.2060.246-2
Income Tax Expense 22.1710.3770.1820.2130.2390.1362.7860.0040.0530.1680.4651.171.0690.3050.2490.3611.0211.4361.160
Net Income -0.7781.311.007-2.0892.0512.0871.28-1.415-0.2571.6252.4144.9064.6873.1590.3720.5351.4881.9012.335-0.02
Net Income Ratio -0.0820.0770.052-0.1040.0950.1070.072-0.091-0.0130.0690.0880.1480.160.1580.0330.0470.0980.1170.164-2
EPS -0.0340.0570.044-0.0910.0890.0910.055-0.061-0.0110.070.110.220.230.150.0180.0260.0750.0980.22-0.074
EPS Diluted -0.0340.0570.044-0.0910.0890.090.055-0.061-0.0110.0690.10.210.20.140.0170.0240.0670.0860.13-0.074
EBITDA -1.1061.3121.226-3.7812.3121.7961.163-0.710.2212.1583.2416.4166.0853.7910.9491.2562.9643.8564.083-0.02
EBITDA Ratio -0.1160.0770.063-0.1880.1070.0920.065-0.0460.0110.0920.1180.1940.2080.190.0840.1090.1950.2380.287-2